TTY Biopharm Company Limited announced earnings results for the full year ended December 31, 2020. For the full year, the company announced sales was TWD 4,221.836 million compared to TWD 4,466.308 million a year ago. Operating income was TWD 957.379 million compared to TWD 1,228.609 million a year ago. Net income was TWD 924.178 million compared to TWD 900.081 million a year ago. Basic earnings per share from continuing operations was TWD 3.72 compared to TWD 3.62 a year ago. Diluted earnings per share from continuing operations was TWD 3.71 compared to TWD 3.61 a year ago.